Surprisingly, and contrary to what was observed in in vitro stimulated T cells, we noticed that ex vivo CD4+ effector T cells from lupus patients express higher levels of BTLA than those from HC, suggesting that lupus Teffs may be efficiently suppressed in vivo. This evidence concerns the gene CD4 and systemic lupus erythematosus.